12399456https://www.upal.com.my/zh/feeds/jobFeedKwongwahArray ( [0] => HTTP/1.1 200 OK [1] => Date: Thu, 09 Oct 2025 10:22:38 GMT [2] => Content-Type: text/xml; charset=utf-8 [3] => Connection: close [4] => Cache-Control: no-cache, private [5] => Cache-Control: no-cache, no-store, must-revalidate [6] => Nel: {"report_to":"cf-nel","success_fraction":0.0,"max_age":604800} [7] => x-frame-options: SAMEORIGIN [8] => x-content-type-options: nosniff [9] => x-xss-protection: 1; mode=block [10] => referrer-policy: strict-origin-when-cross-origin [11] => permissions-policy: geolocation=(), microphone=(), camera=() [12] => content-security-policy: default-src * 'unsafe-inline' 'unsafe-eval' data: blob:; script-src * 'unsafe-inline' 'unsafe-eval' data: blob:; style-src * 'unsafe-inline' data:; img-src * data: blob:; font-src * data:; connect-src *; frame-src *; object-src *; media-src *; child-src *; [13] => Server: cloudflare [14] => x-robots-tag: noindex, nofollow, nosnippet, noarchive [15] => strict-transport-security: max-age=31536000; includeSubDomains; preload [16] => expires: Fri, 10 Oct 2025 10:22:38 GMT [17] => vary: Accept-Encoding [18] => Report-To: {"group":"cf-nel","max_age":604800,"endpoints":[{"url":"https://a.nel.cloudflare.com/report/v4?s=NUMKPv6l2D3CVF0VjpcxfLMNKhsuw4y00dcYPg9OZkk%2Bq1oxL%2Ffy%2BIZxJWFHoaSLRaJotY0sr1Ea1Jhyf6YGbehRic9BEbsEc%2B5X8s4%3D"}]} [19] => cf-cache-status: DYNAMIC [20] => Speculation-Rules: "/cdn-cgi/speculation" [21] => Server-Timing: cfCacheStatus;desc="DYNAMIC" [22] => Server-Timing: cfEdge;dur=3,cfOrigin;dur=79 [23] => Set-Cookie: UpalLiveSession=eyJpdiI6ImhZSm1PTmlDREVJSWJqZU9KZXpNb3c9PSIsInZhbHVlIjoiYlVMUkVibjB1NTM4TXhkU0liNWs4XC9xU1hpTGNJSEQrS2Z2UGs3UHoybUpvdVNOUFBoZUJtb0lJSTdGWHc4azk5ajZtam9xNWZGdXRjbzNlazVNdjdnPT0iLCJtYWMiOiJlMDRkYThjODZmMTcwZGZlMGY3MTQ0NTZhY2UzMDMzYTE4MjIzYzdkMWE4ZDk0YjkwNzEyMjkyN2M2ZWRjODAxIn0%3D; HttpOnly; Path=/; Max-Age=94608000; Expires=Sun, 08 Oct 2028 10:22:38 GMT [24] => CF-RAY: 98bd2870febdd4a9-KUL [25] => alt-svc: h3=":443"; ma=86400 ) 789

 

 

中国国家卫健委和国家中医药管理局于周三发布最新的第7版新冠肺炎诊疗方案，正式确认新的病毒传播途径，从粪便及尿中分离出病毒，提醒民众需注意粪尿污染环境、或造成气雾传播（又称气溶胶）或接触传播；当局亦证实氯己定（或称洗必泰，Chlorhexidine）不能有效消灭病毒。

方案显示，目前所见传染源主要是新型冠状病毒感染的患者，无症状感染者也可能成为传染源。除呼吸道飞沫和密切接触传播途径外，在相对封闭的环境中长时间暴露于高浓度气溶胶情况下，可能出现气雾传播。

方案提出，医疗机构使用中医药在救治工作中有积极作用，结合中西医治疗，有良好效果。中医治疗适合轻微病症、普通型和重型患者，以中药配合治疗，例如清肺排毒汤、化湿败毒汤等。

目前研究显示，病毒与蝙蝠SARS样冠状病毒同源性达85%以上，病毒对紫外线和热敏感，56℃在30分钟，或使用乙醚、75%乙醇、含氯消毒液、过氧乙酸和氯仿等溶剂均可有效灭活病毒。